Repligen | RGEN - هزینه بهره بدهی

قیمت سهام
117.60
تغییر روزانه
3.54 3.10%
ماهیانه
2.87%
سالیانه
-18.76%
Q2 پیش بینی
115.08




هزینه بهره بدهی تغییر دادن تاریخ
Agilent USD 25M 2M 2025-12
Align Technology USD 2M 660K 2023-03
Bio Techne USD 2.18M 173K 2025-06
BioMarin Pharmaceutical USD 2.78M 199K 2025-12
Bristol-Myers Squibb USD 432M 48M 2025-12
Bruker USD 20M 4.3M 2025-09
Charles River Laboratories USD 23.78M 1.63M 2025-12
Danaher USD 63M 8M 2026-03
Dentsply International USD 22M 1000K 2025-12
General Electric Aerospace USD 496M 271M 2025-12
Henry Schein USD 39M 1000K 2025-12
Illumina USD 25M 0 2025-09
IQVIA Holdings USD 193M 4M 2025-12
Mettler Toledo International USD 17.39M 307K 2025-12
Myriad Genetics USD 4.4M 600K 2025-12
OraSure Technologies 1.67M 1.13M 2025-12
Pacific Biosciences Of California USD 1.74M 1000 2025-12
Pfizer USD 711M 59M 2025-12
Repligen USD 5.5M 81K 2025-12
Revvity USD 23.51M 742K 2025-12
Standard Biotools USD 5K 5K 2025-12
Thermo Fisher Scientific USD 354M 11M 2026-03
Waters USD 8.62M 18.02M 2025-12
West Pharmaceutical Services USD 1.9M 1.7M 2026-03